Phase 1b study of cabozantinib administered alone or in combination with atezolizumab for solid tumors
Learn More at Clinicaltrials.govPhase 3 pivotal trial of cabozantinib in patients with radioiodine-refractory differentiated thyroid cancer who have progressed after prior VEGFR (vascular endothelial growth factor receptor)–targeted therapy
Learn More at Clinicaltrials.govPhase 3 study of cabozantinib in combination with atezolizumab compared to sorafenib in advanced treatment-naive HCC (hepatocellular carcinoma)
Learn More at Clinicaltrials.govPhase 3 study of cabozantinib with nivolumab and ipilimumab vs nivolumab and ipilimumab alone in advanced treatment-naive RCC (renal cell carcinoma)
Learn More at Clinicaltrials.govUSES DESCRIBED HERE ARE INVESTIGATIONAL.
SAFETY AND EFFICACY HAVE NOT BEEN ESTABLISHED.